• New
Viropil (PeP) Buyprep.eu
search
  • Viropil (PeP) Buyprep.eu
  • Bottle Viropil (PeP) Buyprep.eu

Viropil (PeP)

€98.00
Not subject to customs clearance

Post-exposure prophylaxis (PeP) is a medical treatment used after a potential exposure to HIV to prevent infection. This treatment should be started as soon as possible, ideally within 24 hours after exposure and no later than 72 hours. The medications used in PeP include a combination of three antiretroviral drugs. Viropil contains Tenofovir disoproxil fumarate, Lamivudine, and Dolutegravir (Tivicay). This medication is administered orally for the 28 days following exposure.

Quantity
Available

Full stock
6
20 Items

Data sheet

Expire date
02/26
Use
PeP

Why Choose Viropil?

  • Early Intervention is Key: PeP must be started as soon as possible after exposure to HIV, ideally within 24 hours and no later than 72 hours. The sooner you start, the more effective the treatment will be in preventing HIV infection.

  • Powerful Antiretroviral Combination: Viropil contains a highly effective combination of three antiretroviral drugs: Tenofovir disoproxil fumarate, Lamivudine, and Dolutegravir (Tivicay). These medications work together to block the virus from replicating and establishing an infection in your body. 

  • Easy Administration: Viropil is administered orally, making it convenient and easy to take. The treatment regimen involves taking the medication daily for 28 days following exposure.
Mylan
  • Pharmaceutical
  • Expiry Date
  • Trademark
  • Supply Length
  • Dosage
  • Presentation
  • Emcure
  • February 2026
  • Truvada + Tivicay
  • 30 days
  • 1 tablet daily
  • Film-Coated Tablets

How Does Viropil Work?

Viropil works by inhibiting the replication of HIV at multiple stages of its lifecycle. Each component of Viropil has a specific role:

  • Tenofovir disoproxil fumarate: This nucleotide reverse transcriptase inhibitor (NRTI) blocks an enzyme that HIV needs to replicate.

  • Lamivudine: Another NRTI, it further prevents the virus from multiplying in your body.

  • Dolutegravir (Tivicay): This integrase strand transfer inhibitor (INSTI) prevents HIV from integrating its genetic material into your cells' DNA, a critical step in the virus's lifecycle.

Who Should Use Viropil?

Viropil is recommended for individuals who may have been exposed to HIV through various means:

  • Unprotected Sexual Contact: If you've had unprotected sex with a partner whose HIV status is unknown or positive.

  • Occupational Exposure: Healthcare workers and others who have been accidentally exposed to HIV through needlesticks or other injuries.

Benefits of Using Viropil

  • High Effectiveness: When taken as prescribed, Viropil significantly reduces the risk of HIV infection.

  • Peace of Mind: Starting PeP promptly can alleviate the anxiety associated with potential HIV exposure.

  • Comprehensive Protection: Viropil's three-drug regimen provides robust protection by targeting the virus at multiple points in its lifecycle.

Important Considerations

  • Adherence to Treatment: It is crucial to take Viropil exactly as prescribed for the full 28-day course to ensure maximum effectiveness.

  • Follow-Up Testing: Regular follow-up with healthcare providers is important. HIV testing is typically recommended at 4-6 weeks, 3 months, and 6 months after exposure.

  • Side Effects: While generally well-tolerated, some individuals may experience mild side effects such as nausea, fatigue, or headaches. Always consult with your healthcare provider regarding any concerns.

Where to Buy Viropil

Viropil is available through our online store. We offer discreet, fast shipping to ensure you receive your medication as quickly as possible.

Act Fast, Stay Protected. Do not wait if you think you've been exposed to HIV. Start Viropil as soon as possible to protect your health. With Viropil, you have the power to prevent HIV infection effectively.

Comments (3)
Grade
No customer reviews for the moment.